What is Evommune 's finance charge?

Evommune (EVMN) reported finance charge of $304 in Q4 2025.

What does finance charge mean?

Reflects the costs incurred by the company related to financing activities, such as fees associated with debt facilities or credit arrangements. Monitoring this helps investors understand the non-interest costs of maintaining the company's capital structure.

Evommune EVMN Finance Charge

Finance Charge at other companies

General Purpose Acquisition Corp. GPAC

$227.19K+14.5%

Our Bond, Inc. OBAI

$20M—

Atlanticus Holdings CorporationATLC

$529.45M+114%

Ivanhoe ElectricIE

$675.25K-39.0%

Credit AcceptanceCACC

$538.4M+2.2%

General Purpose Acquisition Corp. GPAC

$1.7M—

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept meha:FinanceCharge.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's finance charge.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's finance charge?: Evommune (EVMN) reported finance charge of $304 in Q4 2025.
What does finance charge mean?: Reflects the costs incurred by the company related to financing activities, such as fees associated with debt facilities or credit arrangements. Monitoring this helps investors understand the non-interest costs of maintaining the company's capital structure.